POSTER SESSION I STOWELL-ORBISON/AUTOPSY and SURGICAL PATHOLOGY AWARDS COMPETITION Monday, March 3, 2008   —  9:30 AM - 12:00 Noon Convention Center, Exhibit Hall A Click on the blue numbers in parentheses to display abstracts. Click the button next to any title to add to Itinerary Planner... PULMONARY PATHOLOGY Poster# Title and Authors Itinerary Planner 211 TTF-1 Positivity Is a Sensitive Predictor of EGFR Mutation and Treatment Response in Pulmonary Adenocarcinomas, by Pathologist Interpretation and by Image Analysis (1535) J Beheshti, E Sabo, PA Janne, V Joshi, LJ Wang, NI Lindeman - Brigham and Women's Hospital, Boston, MA; Rhode Island Hospital, Brown Medical School, Providence, RI; Dana-Farber Cancer Institute, Boston, MA; Harvard Medical School, Boston, MA Add 212 p16/CDKN2A Deletion as a Diagnostic Marker To Distinguish Benign from Malignant Mesothelial Proliferations (1542) CT-S Chung, GC Santos, DM Hwang, O Ludkovski, J Squire, M-S Tsao - University Health Network, Toronto, ON, Canada; University of Toronto, Toronto, ON, Canada Add 213 Integrative Genomic Microarray Analyses Reveal Novel Molecular Targets in Non-Small Cell Lung Carcinoma (1545) KJ Craddock, D Strumpf, W Xie, TPH Buys, B Chi, WL Lam, I Jurisica, MS Tsao - University Health Network, University of Toronto, Toronto, ON, Canada; University of Toronto, Toronto, ON, Canada; British Columbia Cancer Research Centre, Vancouver, BC, Canada Add 214 Multiple Lung Nodules, Synchronous Primaries Versus Synchronous Metastases: Does It Matter? (1554) DK Durnick, C Couture, JA Wampfler, SD Cassivi, P Yang, MC Aubry - Mayo Clinic, Rochester, MN; Mayo Clinic, Rochester; Laval University, Quebec, Canada Add 215 Lessons Learnt from Mistakes and Deferrals in Frozen Section Diagnosis of Pulmonary Lesions: An Evidence Based Pathology Approach (1560) R Gupta, AS Khuranna, RJ McKenna, AM Marchevsky - Cedars Sinai Medical Center, LA, CA Add 216 Expression of Activated AKT (And Two Other Related Proteins) in Unresectable NSCLC Does Not Correlate with Radiologic Chemoresponse (1562) ML Hearp, ZS Ahmed, PS Talwar, M Wright, K Kaiser, JS Coon, A Tyner, O David - University of Illinois, Chicago; Rush University Medical Center, Chicago Add 217 Evidence-Based Criteria To Distinguish Metastatic Breast Cancer from Primary Lung Neoplasms on Frozen Section (1563) JB Herbst, RA Jenders, RJ McKenna, AM Marchevsky - Cedars-Sinai Medical Center, LA, CA; Cedars-Sinai Medical Center and University of California, Los Angeles, CA Add 218 The Extent of Sarcomatoid Component Is an Independent Predictor of Survival in Malignant Mesothelioma (1565) MD Hofer, WC Foo, DJ Sugarbaker, JM Corson, LR Chirieac - Brigham and Women's Hospital, Boston, MA Add 219 Downregulation of GADD45a Protein Expression Is Associated with Advanced Tumor Stage and Decreased Survival in Squamous Cell Carcinoma of the Lung (1566) SM Homan, CE Sheehan, JS Ross, TA Jennings - Albany Medical College, Albany, NY Add 220 EGFR Molecular and Phenotypic Evaluation in Patients with Pulmonary Adenocarcinoma: A Comparison of Different Methodologies and a Proposal for an Algorithmic Approach to EGFR Testing (1580) AM Marchevsky, R Gupta, AM Dastane, F Forozan, C Riley, J Lopategui - Cedars Sinai Medical Center, LA, CA Add 221 Topoisomerase II-alpha, Minichromosome Maintenance Protein 2, and X-Linked Mammalian Inhibitor of Apoptosis Protein Expression in Pleural Diffuse Malignant Mesothelioma: Possible Role for Chemotherapeutic Intervention (1585) BH Moore, PT Cagle, TC Allen, A Sienko, R Barrios, A Haque, QJ Zhai - Weill College of Medicine Cornell University, The Methodist Hospital, Houston, TX; University of Texas Health Center, Tyler, TX Add 222 Rate of Concordance/Discordance between Bronchial Biopsy and Cytology When Specimens Are Taken on the Same Bronchoscopic Procedure: An Institutional Experience from 2000 to 2005 (1593) MK Sackett, DR Salomao, E Yi, M-C Aubry - Mayo Clinic, Rochester, MN Add 223 Napsin A: A New Marker for Lung Adenocarcinoma Is Complementary and More Sensitive Than TTF-1 (Thyroid Transcription Factor-1): Evaluation of 967 Cases by Tissue Microarray (1594) IM Sainz, J Fukuoka, PT Cagle, J Jagirdar - University of Texas Health Science Center at San Antonio, San Antonio, TX; Toyama University Hospital, Toyama, Japan; Weill College of Medicine Cornell University, The Methodist Hospital, Houston, TX Add 224 EGFR Gene Amplification Is Invariably Associated with Exon 19 Deletion in Non-Small Cell Lung Carcinoma (1600) LM Sholl, AJ Iafrate, B Yeap, A Holmes, YP Chou, MT Wu, YG Goan, L Su, PA Jänne, DC Christiani, LR Chirieac - Brigham and Women's Hospital, Massachusetts General Hospital, and Dana Farber Cancer Institute, Boston, MA; Kaohsiung Veteran General Hospital, Kaohsiung, Taiwan; Harvard School of Public Health, Boston, MA Add